NICHOLAS RAVVIN: Open Payments
NPI 1093278905 · WEST SENECA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,749 in 162 payments from 15 companies in 2025. Trend: 2023 $3,037 · 2024 $2,310 · 2025 $2,749
Food & beverage: $2,749
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $459 |
| Neurocrine BioSciences, Inc. | 20 | $414 |
| Teva Pharmaceuticals USA, Inc. | 18 | $279 |
| Alkermes, Inc. | 17 | $275 |
| Lundbeck LLC | 23 | $237 |
| Axsome Therapeutics, Inc. | 13 | $211 |
| Otsuka America Pharmaceutical, Inc. | 10 | $192 |
| E.R. Squibb & Sons, L.L.C. | 2 | $150 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $138 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $135 |
Products named: VRAYLAR, REXULTI, INGREZZA, ARISTADA, Auvelity, UZEDY, COBENFY, TRINTELLIX.
Industry payments across NY — which companies pay providers there.
